ValuentumAd

Official PayPal Seal
Valuentum Reports













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Dec 19, 2014
Stocks Catapult Back To Near All-Time Highs
The markets seemingly are almost completely dependent on what the Fed does or says.
Dec 3, 2014
Gilead Sciences: The Going Rate for a Stock Analyst These Days?
A nickel an hour…think about it. Now a 6.
Dec 1, 2014
Oct 29, 2014
Gilead’s Revenue More Than Doubles in Third Quarter
Antiviral sales at the company remain strong, and we continue to like opportunities in its pipeline.
Oct 22, 2014
Adding to Gilead and Alibaba in Best Ideas Portfolio; Establishing Kinder Morgan in Dividend Growth Portfolio
The correction has come and passed. It appears the market is setting up to move higher…again. Such a move may still be a part of the beginning of a larger downward trend, however.
Oct 17, 2014
‘The Correction’ May Have Passed But Are We Now In A Bear Market?
The markets rallied today, but next week will be very important. We’re monitoring the credit markets closely for hints on risk-taking and its impact on the direction of the broader equity markets.
Oct 9, 2014
What Members Are Talking About: Ford, Gilead, and Boeing
We like to be an open book to members. Please be sure to reach out to our team at any time.
Sep 19, 2014
What Is Fat Pitch Investing?
We’re taking a few hacks today.
Jul 30, 2014
Big Pharma Round Up
Let’s take a look at recent quarterly results from Big Pharma.
Jun 22, 2014
Valuentum Economic Castle™ Rating Update
Members should expect the initial Economic Castle™ ratings.


Latest News and Media
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.